Nu-Med Plus, Inc.

Nu-Med Plus, Inc. is a U.S.-based medical device company focused on developing nitric oxide technologies for hospital, clinical, research, and mobile delivery applications. The company was formed to design, manufacture, and market nitric oxide generating formulations and delivery systems for use in medical procedures and related laboratory settings.

0.03

0.03

— Nu-Med Plus, Inc.
%
Nitric oxide formulations20% Compound-based technologies designed to generate nitric oxide for medical and research use.
Hospital delivery systems25% Bedside nitric oxide delivery systems intended for hospital use in clinical care settings.
Clinical and rehabilitation devices25% Portable or clinic-based nitric oxide delivery units for medical clinics and rehabilitation centers.
Mobile nitric oxide devices15% Rechargeable mobile devices designed to deliver nitric oxide gas outside fixed hospital settings.
Research systems15% Nitric oxide systems used for non-clinical laboratory and research applications.

Nu-Med Plus targets hospitals, health systems, clinics, rehabilitation centers, and medical professionals that use...

  • Hospitals and health systemsprimary

    Buy bedside nitric oxide delivery systems for inpatient clinical use and procedure support.

  • Clinics and rehabilitation centerssecondary

    Buy clinical nitric oxide units for outpatient or specialty care settings.

  • Research laboratoriessecondary

    Buy nitric oxide systems for non-clinical laboratory and research applications.

  • Medical professionalssecondary

    Influence adoption by specifying devices that address a defined procedural need.

  • International distributors and usersemerging

    Potential buyers of early non-medical or lab-use units outside the U.S. approval pathway.

Nu-Med Plus is headquartered in Port Jefferson, New York and was incorporated in Utah...

  • •Headquartered in Port Jefferson, New York
  • •Incorporated in Utah
  • •U.S. market requires FDA approval for human medical use
  • •International sales depend on local medical device approvals
  • •Non-clinical research units may be sold earlier than medical devices

The company’s strategy is to develop nitric oxide technologies that address specific medical needs and then...

01
Advance nitric oxide device developmentmedium-term

Product development is the basis for future commercialization and market entry.

02
Secure regulatory approvalsmedium-term

Human medical use in the U.S. and abroad requires FDA and foreign agency clearance.

03
Commercialize research and lab-use unitsshort-term

Earlier non-clinical sales could create initial market presence before medical approval.

Nu-Med Plus faces development, regulatory, and financing risk because its products require substantial testing and...

critical

Regulatory approval risk

Human medical use of nitric oxide devices requires FDA and foreign agency approval before sales.

Scope
U.S. and international medical device commercialization
Materiality
high
critical

Financing and going-concern risk

The company has no revenue disclosed and depends on capital infusions to fund development and operations.

Scope
Product development and corporate continuity
Materiality
high
high

Development and commercialization risk

Devices may not reach market acceptance or may take longer and cost more than expected to develop.

Scope
Nitric oxide delivery systems and research products
Materiality
high
medium

Customer adoption risk

Hospitals and clinicians may be slow to adopt a new nitric oxide platform versus existing alternatives.

Scope
Hospital, clinic, and rehabilitation customers
Materiality
medium
low

Credit risk on receivables

If sales begin, the company may need allowances for doubtful accounts when customers delay payment.

Scope
Trade receivables
Materiality
low
Revenue recognition
Will affect reported sales timing once commercialization starts
Allowance for doubtful accounts
Could affect net revenue and operating results
Income taxes and deferred tax assets
Could affect balance sheet assets and tax expense

Nuo Therapeutics, Inc.

AURX · Surgical & Medical Instruments & Apparatus

Nuwellis, Inc.

NUWE · Electromedical & Electrotherapeutic Apparatus

CalciMedica, Inc.

CALC · Pharmaceutical Preparations

Nuvalent, Inc.

NUVL · Pharmaceutical Preparations

NU SKIN ENTERPRISES, INC.

NUS · Wholesale-Drugs, Proprietaries & Druggists' Sundries

Modular Medical, Inc.

MODD · Surgical & Medical Instruments & Apparatus

: 29.4.2026